Cytek Biosciences, Inc. (CTKB)
4.16
+0.17
(+4.26%)
USD |
NASDAQ |
May 28, 14:43
Cytek Biosciences EPS Diluted (Quarterly) : -0.1466 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Standard BioTools, Inc. | -0.1165 |
| Rapid Micro Biosystems, Inc. | -0.3142 |
| Henry Schein, Inc. | 0.9219 |
| Accendra Health, Inc. | -0.0846 |
| Itonis, Inc. | 0.00 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.87M |
| Revenue (Quarterly) | 44.14M |
| Total Expenses (Quarterly) | 63.00M |
| Enterprise Value | 289.38M |
| Gross Profit Margin (Quarterly) | 48.16% |
| Profit Margin (Quarterly) | -42.75% |
| Earnings Yield | -13.88% |
| Normalized Earnings Yield | -13.88 |